Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen stock lifts as much as 3% as MS drugs propel third-quarter beat
Biogen stock lifts as much as 3% as MS drugs propel third-quarter beat
Biogen stock lifts as much as 3% as MS drugs propel third-quarter beat
Submitted by
admin
on October 27, 2016 - 9:00am
Source:
Marketwatch
News Tags:
Biogen
earnings
Headline:
Biogen stock lifts as much as 3% as MS drugs propel third-quarter beat
Do Not Allow Advertisers to Use My Personal information
